Revolution Health Radio RHR: Revolutionizing Cancer Treatment, with Dr. Chris Apfel
Nov 5, 2024
In this enlightening conversation, Dr. Chris Apfel, founder of SageMedic, shares his passion for revolutionizing cancer treatment through precision medicine. With a rich background in medical research, he discusses the innovative SAGE Oncotest, which personalizes therapy based on individual tumors. Dr. Apfel highlights challenges in traditional cancer therapies and the importance of patient advocacy. He also explores advanced techniques like micro tumors for testing, emphasizing the role of lifestyle changes and emerging technologies in enhancing cancer care.
AI Snips
Chapters
Books
Transcript
Episode notes
Personal Motive Behind The Test
- Dr. Chris Apfel’s father declined cancer therapy because he wanted a guaranteed outcome after witnessing his wife suffer from chemotherapy.
- That personal loss drove Apfel to develop better, individualized cancer testing methods.
Limits Of Genomic Reductionism
- Genomic testing is reductionistic and misses tumor complexity like microenvironment and proteomics.
- You cannot reliably predict drug response from DNA alone because tumors are more than the sum of their parts.
Actively Manage Your Care
- Assemble a support structure and use patient advocates immediately after diagnosis.
- Get a second opinion because it improves outcomes in about 23–57% of cases.
